secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2026-05-27T20:20:15+00:00
Accession:  0001193125-26-241940
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics announces 2026 annual meeting voting results; all director nominees elected
--------------------------------------------------------------------------------

- Elected all six director nominees: Woods, Henson, Martinez-Davis, Morich, Spoor, Williamson.
- Ratified WithumSmith+Brown as independent auditor for FY2026 with 97.6M votes for.
- Non-binding advisory vote favored annual say-on-pay; Board adopts 1-year frequency.
- 97,882,462 shares (85.85% of outstanding) represented at meeting, forming quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000119312526241940/0001193125-26-241940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000119312526241940/catx-20260527.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-241940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer